Top Buy
Security | Buy | Sell | Buy (1W) ▲ | Sell (1W) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Omeros Corp. | 2 | 2 | 0 | 0 | €3.34 | - | - |
Amgen Inc. | 28 | 0 | 0 | 0 | €300.15 | €304.82 | 1.555% |
Baxter International | 3 | 0 | 0 | 0 | €35.86 | €46.00 | 28.263% |
Quest Diagnostics Inc. | 7 | 0 | 0 | 0 | €138.60 | €145.02 | 4.631% |
Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 0 | 0 | €50.50 | €50.00 | -0.990% |
Deciphera Pharmaceuticals | 6 | 0 | 0 | 0 | €23.80 | €24.97 | 4.929% |
Prothena Corp. plc | 13 | 0 | 0 | 0 | €18.80 | €78.70 | 318.620% |
Resmed Inc. | 19 | 0 | 0 | 0 | €224.70 | €216.62 | -3.594% |
QuidelOrtho Corp. | 9 | 2 | 0 | 0 | €40.80 | €59.81 | 46.589% |
Innoviva Inc. | 6 | 0 | 0 | 0 | €17.50 | €30.00 | 71.429% |
Ensign Group Inc. | 9 | 0 | 0 | 0 | €138.00 | €125.13 | -9.326% |
Humana Inc. | 23 | 0 | 0 | 0 | €290.20 | €378.23 | 30.333% |
G1 Therapeutics | 19 | 1 | 0 | 0 | €6.45 | €11.09 | 71.926% |
Brainstorm Cell | 2 | 0 | 0 | 0 | €0.24 | €1.84 | 676.744% |
Bio-Rad Labs Inc. A | 6 | 0 | 0 | 0 | €290.70 | €366.66 | 26.131% |
Omnicell Inc. | 3 | 2 | 0 | 0 | €38.80 | €36.13 | -6.879% |
Lantheus Holdings Inc | 2 | 0 | 0 | 0 | €95.34 | - | - |
Avid Bioservices Inc | 2 | 0 | 0 | 0 | €10.00 | €10.00 | 0.000% |
Xencor Inc. | 16 | 0 | 0 | 0 | €18.70 | €31.38 | 67.809% |
Bio-Techne Corp. | 9 | 0 | 0 | 0 | €67.00 | €75.80 | 13.139% |
Healthequity Inc. | 2 | 0 | 0 | 0 | €69.00 | €82.25 | 19.203% |
Charles River Labs Intl | 12 | 0 | 0 | 0 | €175.65 | €247.61 | 40.966% |
Veeva Systems A | 2 | 0 | 0 | 0 | €196.85 | - | - |
Heron Therapeutics Inc. | 11 | 1 | 0 | 0 | €1.68 | €4.63 | 174.691% |
Alnylam Pharmace. | 45 | 0 | 0 | 0 | €239.50 | €274.99 | 14.818% |